Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps.

Christopher M LowAllan R WangMichael YongJayakar V Nayak Zara M Patel Peter H Hwang

Published in: International forum of allergy & rhinology (2024)

Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.

Keyphrases

chronic rhinosinusitis
atopic dermatitis
primary care
minimally invasive
healthcare
coronary artery bypass
emergency department
coronary artery disease
risk assessment
human health
adverse drug
rectal cancer
electronic health record